Managing New Technologies in Conceptual Engineering Design, Demonstrated on Innovative Positive Displacement Device

2007 ◽  
Author(s):  
H. M. Roser ◽  
W. J. Dartnall
Keyword(s):  
Engineering Design ◽  
Development Time ◽  
Conceptual Development ◽  
New Technologies ◽  
Cost Effective ◽  
Evaluation Framework ◽  
Design Issues ◽  
Simple Method ◽  
Critical Design ◽  
Positive Displacement

In this work, a simple method is presented, assisting engineering designers in dealing with innovative technologies during the conceptual phase of engineering design. The technique emphasises on determining Critical Design Issues, as well as evaluating new technologies early on in order to define a Critical Design Path. Since time and budget constraints often demand prompt design decisions, a systematic, easy-to-follow concept analysis and evaluation framework is introduced, allowing engineers to quickly identify critical design issues. The proposed method is demonstrated using the conceptual development of an innovative positive displacement device as a case study. The study indicates that, particularly in absence of essential knowledge within early development stages, experimental design can provide a cost effective method of identifying potential design problems, and thus, reducing design iterations, development time and risk, as long as a suitable design process is also in place. The evaluation of potential design solutions can be achieved by conceptual prototypes, which may represent a specific critical technology, or embody initial ideas to quickly gain knowledge that is crucial for the development of new design concepts. This allows the designer to reduce intuition and guesswork, whilst detecting unanticipated effects and phenomena, delivering deeper insight and communicating ideas. The method proved to be a significant tool for rapid and goal-oriented conceptual design. Through the proliferation of recent prototyping technologies, along with a reduction of design iterations, the concepts could be developed and verified on a low budget over a short development time.

scholarly journals Innovating on Inhaled Bioequivalence: A Critical Analysis of the Current Limitations, Potential Solutions and Stakeholders of the Process

Pharmaceutics ◽  
2021 ◽  
Vol 13 (7) ◽  
pp. 1051
Author(s):  
Jonattan Gallegos-Catalán ◽  
Zachary Warnken ◽  
Tania F. Bahamondez-Canas ◽  
Daniel Moraga-Espinoza
Keyword(s):  
New Technologies ◽  
Innovation Process ◽  
Cost Effective ◽  
Regulatory Agencies ◽  
Drug Products ◽  
Effective Strategies ◽  
Rate Analysis ◽  
Orally Inhaled Drug Products ◽  
Next Generation Impactor ◽  
First Time

Orally inhaled drug products (OIDPs) are an important group of medicines traditionally used to treat pulmonary diseases. Over the past decade, this trend has broadened, increasing their use in other conditions such as diabetes, expanding the interest in this administration route. Thus, the bioequivalence of OIDPs is more important than ever, aiming to increase access to affordable, safe and effective medicines, which translates into better public health policies. However, regulatory agencies leading the bioequivalence process are still deciding the best approach for ensuring a proposed inhalable product is bioequivalent. This lack of agreement translates into less cost-effective strategies to determine bioequivalence, discouraging innovation in this field. The Next-Generation Impactor (NGI) is an example of the slow pace at which the inhalation field evolves. The NGI was officially implemented in 2003, being the last equipment innovation for OIDP characterization. Even though it was a breakthrough in the field, it did not solve other deficiencies of the BE process such as dissolution rate analysis on physiologically relevant conditions, being the last attempt of transferring technology into the field. This review aims to reveal the steps required for innovation in the regulations defining the bioequivalence of OIDPs, elucidating the pitfalls of implementing new technologies in the current standards. To do so, we collected the opinion of experts from the literature to explain these trends, showing, for the first time, the stakeholders of the OIDP market. This review analyzes the stakeholders involved in the development, improvement and implementation of methodologies that can help assess bioequivalence between OIDPs. Additionally, it presents a list of methods potentially useful to overcome some of the current limitations of the bioequivalence standard methodologies. Finally, we review one of the most revolutionary approaches, the inhaled Biopharmaceutical Classification System (IBCs), which can help establish priorities and order in both the innovation process and in regulations for OIDPs.

scholarly journals 400 - Effects of Computerized Cognitive Training with an Elderly Community Sample

2020 ◽  
Vol 32 (S1) ◽  
pp. 116-116
Author(s):  
M Pires ◽  
A Antunes ◽  
C Gameiro ◽  
C Pombo
Keyword(s):  
Older Adults ◽  
Cognitive Training ◽  
New Technologies ◽  
Community Sample ◽  
Cost Effective ◽  
Well Being ◽  
Control Group ◽  
Depression Symptoms ◽  
Intensive Training ◽  
Before And After

Community-focused programs that promote active and healthy aging can help preserve cognitive capacities, prevent or reverse cognitive deficits. Computer-based cognitive training (CCT) is a promising non-pharmacological, cost -effective and accessible intervention to face the effects of age-related cognitive decline. Previous studies proved CCT to have equal or better efficacy compared to traditional interventions. This comparative multifactorial study aims to test the efficacy of a CCT in a non-randomized community sample of 74 older adults: G1-CCT Experimental group (n=43) (Mean age M=72.21, SD=12.65) and G2- Paper-Pencil Control group (n=31; M=77.94, SD=10.51). Pensioners (97.3%), mostly women (83.8 %) with basic education (51.4%) and without dementia diagnosis, completed a cognitive training program of 17 or 34 group sessions (twice a week). G2 undertook a classic cognitive paper-pencil stimuli tasks. G1, performed, additionally, individual CCT with COGWEB® in a multimodal format (intensive training of attention, calculation, memory, gnosis, praxis, executive functions). Both groups completed Portuguese versions of Mini -Mental State Examination (MMSE),Montreal Cognitive Assessment (MOCA); Geriatric Depressive Scale (GDS); Mini Dependence Assessment (MDA); WHOOQL 5 and Social Support Satisfaction Scale (ESSS) before and after participating in the program. Both groups reported better post-test scores on basic cognitive functions (MMSE, MOCA), Depression symptoms (GDS-30), subjective well-being and quality of life (WHOOQL-5). G1 presented higher MOCA and lower GDS scores before and after CCT, although, group differences become less expressive when interaction effects are considered. Results are in line with findings from past studies, CCT supported by the new technologies, is as a relevant cost-effective therapeutic tool for health professionals working with older adults. Particularly for preventive purposes of neuro-cognitive disorders.

scholarly journals mRNA-Based Vaccines

Vaccines ◽  
2021 ◽  
Vol 9 (4) ◽  
pp. 390
Author(s):  
Frank Kowalzik ◽  
Daniel Schreiner ◽  
Christian Jensen ◽  
Daniel Teschner ◽  
Stephan Gehring ◽  
...  
Keyword(s):  
Large Scale ◽  
New Technologies ◽  
Vaccine Development ◽  
Effective Means ◽  
Cost Effective ◽  
Clinical Applications ◽  
Cell Mediated Immunity ◽  
Healthy Individuals ◽  
Emerging Pathogens ◽  
Cell Genome

Increases in the world’s population and population density promote the spread of emerging pathogens. Vaccines are the most cost-effective means of preventing this spread. Traditional methods used to identify and produce new vaccines are not adequate, in most instances, to ensure global protection. New technologies are urgently needed to expedite large scale vaccine development. mRNA-based vaccines promise to meet this need. mRNA-based vaccines exhibit a number of potential advantages relative to conventional vaccines, namely they (1) involve neither infectious elements nor a risk of stable integration into the host cell genome; (2) generate humoral and cell-mediated immunity; (3) are well-tolerated by healthy individuals; and (4) are less expensive and produced more rapidly by processes that are readily standardized and scaled-up, improving responsiveness to large emerging outbreaks. Multiple mRNA vaccine platforms have demonstrated efficacy in preventing infectious diseases and treating several types of cancers in humans as well as animal models. This review describes the factors that contribute to maximizing the production of effective mRNA vaccine transcripts and delivery systems, and the clinical applications are discussed in detail.

The Multi-Relationship Evaluation Design Framework: Designing Testing Plans to Comprehensively Assess Advanced and Intelligent Technologies

2010 ◽  
Author(s):  
Brian A. Weiss ◽  
Linda C. Schmidt ◽  
Harry A. Scott ◽  
Craig I. Schlenoff
Keyword(s):  
Intelligent Systems ◽  
New Technologies ◽  
Evaluation Framework ◽  
Evaluation Design ◽  
Design Elements ◽  
Summative Assessments ◽  
Extensive Evaluation ◽  
Level Of Knowledge ◽  
Definition Of ◽  
Key Terms

As new technologies develop and mature, it becomes critical to provide both formative and summative assessments on their performance. Performance assessment events range in form from a few simple tests of key elements of the technology to highly complex and extensive evaluation exercises targeting specific levels and capabilities of the system under scrutiny. Typically the more advanced the system, the more often performance evaluations are warranted, and the more complex the evaluation planning becomes. Numerous evaluation frameworks have been developed to generate evaluation designs intent on characterizing the performance of intelligent systems. Many of these frameworks enable the design of extensive evaluations, but each has its own focused objectives within an inherent set of known boundaries. This paper introduces the Multi-Relationship Evaluation Design (MRED) framework whose ultimate goal is to automatically generate an evaluation design based upon multiple inputs. The MRED framework takes input goal data and outputs an evaluation blueprint complete with specific evaluation elements including level of technology to be tested, metric type, user type, and, evaluation environment. Some of MRED’s unique features are that it characterizes these relationships and manages their uncertainties along with those associated with evaluation input. The authors will introduce MRED by first presenting relationships between four main evaluation design elements. These evaluation elements are defined and the relationships between them are established including the connections between evaluation personnel (not just the users), their level of knowledge, and decision-making authority. This will be further supported through the definition of key terms. An example will be presented in which these terms and relationships are applied to the evaluation design of an automobile technology. An initial validation step follows where MRED is applied to the speech translation technology whose evaluation design was inspired by the successful use of a pre-existing evaluation framework. It is important to note that MRED is still in its early stages of development where this paper presents numerous MRED outputs. Future publications will present the remaining outputs, the uncertain inputs, and MRED’s implementation steps that produce the detailed evaluation blueprints.

Pipeline Bundle: A Smart Solution for Infield Transportation—Part 1: Overview and Engineering Design

2009 ◽  
Author(s):  
R. Song ◽  
Z. Kang ◽  
Yuanlong Qin ◽  
Chunrun Li
Keyword(s):  
Engineering Design ◽  
Thermal Performance ◽  
Oil And Gas ◽  
Cost Effective ◽  
Companion Paper ◽  
Transportation Engineering ◽  
Innovative Solution ◽  
Water Pipeline ◽  
Protection Potential ◽  
Offshore Oil And Gas

Pipeline bundle system consisting of carrier pipe, sleeve pipe and internal flowlines offers innovative solution for the infield transportation of oil and gas. Due to its features, pipeline bundle offers a couple of advantages over conventional pipeline in particular for cases where multi-flowlines and high thermal performance are of great interests. The main benefits and advantages of such system include excellent thermal performance to prevent wax formation and hydrates, multiple bundled flowlines, mechanical and corrosion protection, potential reuse, etc. With the developments of offshore oil and gas industries, more and more hydrocarbon resources are being explored and discovered from shallow to deep water. Pipeline bundle system can be a smart solution for certain applications, which can be safe and cost effective solution. The objective of this paper is to overview pipeline bundle technology, outline detailed engineering design issue and procedure. Focus is given to its potential application in offshore for infield transportation. Engineering design principles and procedures for pipeline bundle system has been highlighted. A companion paper addressed the details of the construction and installation of pipeline bundle system. An example is given at the end of this paper to demonstrate the pipeline bundle system concept and its application.

scholarly journals Innovation Pathways in the NHS: An Introductory Review

2021 ◽  
Author(s):  
Anmol Arora ◽  
Andrew Wright ◽  
Mark Cheng ◽  
Zahra Khwaja ◽  
Matthew Seah
Keyword(s):  
Health Care ◽  
National Health ◽  
Health Care Professionals ◽  
New Technologies ◽  
Care Delivery ◽  
Cost Effective ◽  
Care Models ◽  
Set Up ◽  
The Uk ◽  
Introductory Review

AbstractHealthcare as an industry is recognised as one of the most innovative. Despite heavy regulation, there is substantial scope for new technologies and care models to not only boost patient outcomes but to do so at reduced cost to healthcare systems and consumers. Promoting innovation within national health systems such as the National Health Service (NHS) in the United Kingdom (UK) has been set as a key target for health care professionals and policy makers. However, while the UK has a world-class biomedical research industry, several reports in the last twenty years have highlighted the difficulties faced by the NHS in encouraging and adopting innovations, with the journey from idea to implementation of health technology often taking years and being very expensive, with a high failure rate. This has led to the establishment of several innovation pathways within and around the NHS, to encourage the invention, development and implementation of cost-effective technologies that improve health care delivery. These pathways span local, regional and national health infrastructure. They operate at different stages of the innovation pipeline, with their scope and work defined by location, technology area or industry sector, based on the specific problem identified when they were set up. In this introductory review, we outline each of the major innovation pathways operating at local, regional and national levels across the NHS, including their history, governance, operating procedures and areas of expertise. The extent to which innovation pathways address current challenges faced by innovators is discussed, as well as areas for improvement and future study.

Coating of Polystyrene Surface with REDV-Gelatin Conjugate for Selective Isolation of Endothelial Cells

2021 ◽  
Vol 904 ◽  
pp. 287-292
Author(s):  
Wan Song Zhang ◽  
Ya Jie Fu ◽  
Rui Wang ◽  
Xuan Hui Qiu ◽  
Ze Yuan Feng ◽  
...  
Keyword(s):  
Endothelial Cells ◽  
Vascular Function ◽  
Flow Cytometric Analysis ◽  
Internal Surface ◽  
Cost Effective ◽  
Cell Viability Assay ◽  
Simple Method ◽  
Migration Assay ◽  
Gelatin Coating

Endothelial cells (EC), which line the internal surface of blood vessels, play various essential roles in controlling vascular function. The mouse is an important animal model for the study of vascular biology and cardiovascular diseases. However, the isolation of primary EC from the murine aorta is challenging because they are readily contaminated by smooth muscle cells (SMC). A previous study developed a simple method to isolate murine EC from SMC. By taking advantage of the differential sedimentation rate between the two cells, the EC was selectively enriched with collagen-coated polystyrene surfaces. Our study further improved this method by introducing a biomimetic peptide REDV (Arg-Glu-Asp-Val), which may bind specifically to EC but not to SMC or fibroblasts. Firstly, REDV-gelatin conjugate was synthesized by using the amine-to-sulfhydryl crosslinker SMCC. REDV-gelatin coating was then prepared on polystyrene surfaces, and their affinities to EC and SMC were subsequently investigated. Fluorescence microscopy and flow cytometric analysis showed that EC adhesion to the gelatin coating was significantly promoted by REDV peptide conjugation. Moreover, cell migration assay and cell viability assay also showed that the conjugation of REDV does not affect EC migration, and this coating did not show cytotoxicity against EC. This gelatin-REDV coating provides a cost-effective and straightforward tool for isolating EC from SMC, which may facilitate in vitro investigations of EC from mice.

Molding of Three-Dimensional Microcomponents

2006 ◽  
Author(s):  
W. N. P. Hung ◽  
M. M. Agnihotri ◽  
M. Y. Ali ◽  
S. Yuan
Keyword(s):  
Focused Ion Beam ◽  
New Technologies ◽  
Electrical Discharge Machining ◽  
Ion Beam ◽  
Semiconductor Industry ◽  
Three Dimensional ◽  
Cost Effective ◽  
Molecular Structures ◽  
Minimum Size ◽  
Ion Beam Sputtering

Traditional micromanufacturing has been developed for semiconductor industry. Selected micro electrical mechanical systems (MEMS) have been successfully developed and implemented in industry. Since current MEMS are designed for manufacture using microelectronics processes, they are limited to two-dimensional profiles and semiconductor based materials. Such shape and material constraints would exclude many applications that require biocompatibility, dynamic stress, and high ductility. New technologies are sought to fabricate three dimensional microcomponents using robust materials for demanding applications. To be cost effective, such microdevices must be economically mass producible. Molding is one of the promising replication techniques to mass produce components from polymers and polymer-based composites. This paper presents the development of a micromolding process to produce thermoplastic microcomponents. Mold design required precision fitting and was integrated with a vacuum pump to minimize air trap in mold cavities. Nickel and aluminum mold inserts were used for the study; their cavities were fabricated by combinations of available micromachining processes like laser micromachining, micromilling, micro electrical discharge machining, and focused ion beam sputtering. High and low density polyethylene, polystyrene polymers were used for this study. The effects of polymer molecular structures, molding temperature, time, and pressure on molding results were studied. Simulation of stress in the microcomponents, plastic flow in microchannels, and mold defects was performed and compare with experimental data. The research results showed that a microcomponent can be fabricated to the minimum size of 10 ± 1μm (0.0004 inch) with surface roughness <10 nm Rt. Molding of micro-size geartrains and orthopedic meso-size fasteners was completed to illustrate the capability of this process.

Sign in / Sign up

Export Citation Format

Share Document